Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Using Cell-Free DNA 5-Hydroxymethylation Signatures
David Haan, Samuel Levy(ID Genomics (United States)), Tierney Phillips, Adriana Pitea(ID Genomics (United States)), Maryam Nabiyouni, Micah Collins(ID Genomics (United States)), Judy Sheard(ID Genomics (United States)), Yuhong Ning(Brown University), Roman E. Reggiardo(University of California, Santa Cruz), Bill Gibb, Carolina Fraire, Michael Riviere(ID Genomics (United States)), Wayne Volkmuth, Anna Bergamaschi, Eric Nilson, Verena Friedl, Michael Kesling, Vanessa Lopez(ID Genomics (United States)), Gulfem D. Guler, Kyle Hazen, Melissa Peters(ID Genomics (United States)), Shimul Chowdhury, Steve Bates(ID Genomics (United States)), Aaron Scott(Theranostics (New Zealand)), Roger Malta, Albert Nguyen(ID Genomics (United States)), Michael Antoine
Cited by 3
Related Papers
Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer
|Science Signaling|2014|166
Artificial intelligence enables comprehensive genome interpretation and nomination of candidate diagnoses for rare genetic diseases
|Genome Medicine|2021|154
An age-progressive platelet differentiation path from hematopoietic stem cells causes exacerbated thrombosis
|Cell|2024|102
Variant <i>STAT4</i> and Response to Ruxolitinib in an Autoinflammatory Syndrome
|New England Journal of Medicine|2023|78